abstract |
NOVEL ANTITUMORAL USE OF CABAZITAXEL AVENTIS PHARMA S.A. Abstract The invention relates to a compound of formula: CH3 o O O CH3 H3C -- H C CH 0 HC HN,,- CH which may be in base form or in the form of a hydrate or a solvate, in combination with prednisone or prednisolone, for its use as a medicament in the treatment of prostate cancer, particularly metastatic prostate cancer, especially for patients who are not catered for by a taxane-based treatment. |